Patrick J. Nolan

Array ( [id] => 6429327 [patent_doc_number] => 20020127227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'RHAMM antagonist antibodies' [patent_app_type] => new [patent_app_number] => 10/140555 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8887 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127227.pdf [firstpage_image] =>[orig_patent_app_number] => 10140555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786207 [patent_doc_number] => 20020159953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Method to diagnose and monitor cellular immune deficiencies' [patent_app_type] => new [patent_app_number] => 10/137769 [patent_app_country] => US [patent_app_date] => 2002-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3783 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20020159953.pdf [firstpage_image] =>[orig_patent_app_number] => 10137769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6559405 [patent_doc_number] => 20020164633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Cell-based assay for detecting activation of poly (ADP-ribose) polymerase' [patent_app_type] => new [patent_app_number] => 10/125326 [patent_app_country] => US [patent_app_date] => 2002-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5558 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164633.pdf [firstpage_image] =>[orig_patent_app_number] => 10125326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157735 [patent_doc_number] => 20020146774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Smad2 phosphorylation and interaction with Smad4' [patent_app_type] => new [patent_app_number] => 10/119099 [patent_app_country] => US [patent_app_date] => 2002-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21189 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146774.pdf [firstpage_image] =>[orig_patent_app_number] => 10119099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7613098 [patent_doc_number] => 06902735 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Antibodies to human IL-17F and other CTLA-8-related proteins' [patent_app_type] => utility [patent_app_number] => 10/102080 [patent_app_country] => US [patent_app_date] => 2002-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 12781 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/902/06902735.pdf [firstpage_image] =>[orig_patent_app_number] => 10102080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774164 [patent_doc_number] => 20030017502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Methods involving the use of capG as a diagnostic marker and methods for the identification of capG modulators for the treatment and prevention of osteoporosis and related disease states' [patent_app_type] => new [patent_app_number] => 10/098931 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4860 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017502.pdf [firstpage_image] =>[orig_patent_app_number] => 10098931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270333 [patent_doc_number] => 20040058851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Specific autoimmune reactions against isomerised/optically inverted epitopes: application for diagnosis of autoimmune diseases' [patent_app_type] => new [patent_app_number] => 10/075372 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15688 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058851.pdf [firstpage_image] =>[orig_patent_app_number] => 10075372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829167 [patent_doc_number] => 20030180225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Walnut and ryegrass allergens' [patent_app_type] => new [patent_app_number] => 10/067620 [patent_app_country] => US [patent_app_date] => 2002-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22386 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180225.pdf [firstpage_image] =>[orig_patent_app_number] => 10067620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 743514 [patent_doc_number] => 07025960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Use of beta-glucuronidase not in combination with allergens for the preparation of medicaments for the treatment of immune or allergic diseases' [patent_app_type] => utility [patent_app_number] => 10/059672 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1159 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/025/07025960.pdf [firstpage_image] =>[orig_patent_app_number] => 10059672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6554727 [patent_doc_number] => 20020164342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Recombinant cat allergen, Fel dI, expressed in baculovirus for diagnosis and treatment of cat allergy' [patent_app_type] => new [patent_app_number] => 10/054444 [patent_app_country] => US [patent_app_date] => 2002-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1471 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164342.pdf [firstpage_image] =>[orig_patent_app_number] => 10054444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462243 [patent_doc_number] => 20020150572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Methods and compositions for the treatment of psoriasis' [patent_app_type] => new [patent_app_number] => 09/990205 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13484 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150572.pdf [firstpage_image] =>[orig_patent_app_number] => 09990205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128373 [patent_doc_number] => 20020076404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Treating atopic dermatitis with IgE antagonists' [patent_app_type] => new [patent_app_number] => 09/991224 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076404.pdf [firstpage_image] =>[orig_patent_app_number] => 09991224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1136398 [patent_doc_number] => 06780413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders' [patent_app_type] => B2 [patent_app_number] => 10/005512 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9940 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780413.pdf [firstpage_image] =>[orig_patent_app_number] => 10005512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860499 [patent_doc_number] => 20030091507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'GLP-1 as a diagnostic test to determine beta-cell function and the presence of the condition of IGT and type-II diabetes' [patent_app_type] => new [patent_app_number] => 10/055259 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7871 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091507.pdf [firstpage_image] =>[orig_patent_app_number] => 10055259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972041 [patent_doc_number] => 06936426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Detection of antibody mediated inflammatory auto-immune disorders' [patent_app_type] => utility [patent_app_number] => 10/046651 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7708 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936426.pdf [firstpage_image] =>[orig_patent_app_number] => 10046651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024347 [patent_doc_number] => 06884574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Methods of identifying agents which inhibit GPR-9-6' [patent_app_type] => utility [patent_app_number] => 09/966755 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 61 [patent_no_of_words] => 19120 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884574.pdf [firstpage_image] =>[orig_patent_app_number] => 09966755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1167548 [patent_doc_number] => 06753135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-22 [patent_title] => 'Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders' [patent_app_type] => B2 [patent_app_number] => 09/956757 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9914 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753135.pdf [firstpage_image] =>[orig_patent_app_number] => 09956757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1031258 [patent_doc_number] => 06878812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-12 [patent_title] => 'Metalloproteinases' [patent_app_type] => utility [patent_app_number] => 09/950688 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22653 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878812.pdf [firstpage_image] =>[orig_patent_app_number] => 09950688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 739997 [patent_doc_number] => 07029686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Variants of Phleum pratense allergenic proteins' [patent_app_type] => utility [patent_app_number] => 09/949888 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2254 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/029/07029686.pdf [firstpage_image] =>[orig_patent_app_number] => 09949888 [rel_patent_id] =>[rel_patent_doc_number] =>)